Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves

Author： Marcy Todd R.   Truong Teresa   Rai Andrea  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.30, Iss.11, 2015-11, pp. : 644-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation: Impact of Bioavailability on Costs and Outcomes

By Nicole Mittmann   Paul I. Oh   Scott E. Walker   William R. Bartle  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 671-683

Adis International

Access to resources Recommend Favorite

Ocular Bleeding Related to Warfarin Anticoagulation in Patients with Mechanical Heart Valve and Atrial Fibrillation

By Biyik I   Mercan I   Ergene O   Oto O  

The Journal of International Medical Research, Vol. 35, Iss. 1, 2007-01 ,pp. : 143-149

Field House Publishing

Access to resources Recommend Favorite

Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants

By  

Current Clinical Pharmacology, Vol. 7, Iss. 3, 2012-08 ,pp. : 175-194

Bentham Science Publishers

Access to resources Recommend Favorite

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim   Schott Gisela  

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite